Predominance of subtype A and G HIV type 1 in Nigeria, with geographical differences in their distribution

AIDS Research and Human Retroviruses

Volumn 16, Issue 4, 2000, Pages 315-325

  Peeters, Martine ^a   Esu Williams, Eka ^b   Vergne, Laurence ^a   Montavon, Celine ^a   Mulanga Kabeya, Claire ^a   Harry, Takena ^c   Ibironke, Akinsete ^d   Lesage, Denis ^e   Patrel, Delphine ^a   Delaporte, Eric ^a  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^b UNIVERSITY OF CALABAR   (Nigeria)

^c UNIVERSITY OF MAIDUGURI   (Nigeria)

^d LAGOS UNIVERSITY TEACHING HOSPITAL   (Nigeria)

^e Inst de Med et d'Epidemiol A   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; FEMALE; GEOGRAPHIC DISTRIBUTION; HETERODUPLEX ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MAJOR CLINICAL STUDY; MALE; NIGERIA; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIRUS CLASSIFICATION; VIRUS ENVELOPE; VIRUS ISOLATION; VIRUS RECOMBINANT;

ADOLESCENT; ADULT; EPIDEMIOLOGY, MOLECULAR; FEMALE; GENES, ENV; GENES, GAG; HETERODUPLEX ANALYSIS; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NIGERIA; PHYLOGENY; PREVALENCE; SEQUENCE ANALYSIS, DNA;

EID: 0034008362     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922200309197     Document Type: Article

References (46)

1. 1. Simon F, Mauclere P, Roques P, et al.: Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nature Med 1998; 4: 1032-1037.
2. 2. Korber B, Myers G, Foley B, et al.: Human Retroviruses and AIDS: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. Los Alamos National Laboratory, Los Alamos, New Mexico, 1997.
3. 3. European Commission and the Joint United Nations Programme on HIV/AIDS: HIV-1 subtypes: Implications for epidemiology, pathogenicity, vaccines and diagnostics. Workshop Report. AIDS 1997; 11: UNAIDS 17-UNAIDS36.
4. 4. Janssens W, Buve A, and Nkengasong JN: The puzzle of HIV-1 subtypes in Africa. AIDS 1997; 11: 705-712.
5. 5. Kanki PJ, Peeters M, and Gueye-Ndiaye A: Virology of HIV-1 and HIV-2: Implications for Africa. AIDS 1997; 11(Suppl. B): S33-S42.
6. 6. Robertson DL, Hahn B, and Sharp PM: Recombination in AIDS. J Mol Evol 1995; 40: 249-259.
7. 7. Robertson DL, Gao F, Hahn BH, and Sharp PM: Intersubtype recombinant HIV-1 sequences. In: Human Retroviruses and AIDS, part III. Los Alamos National Laboratory, Los Alamos, New Mexico, 1997, pp. 25-30.
8. 8. Gao F, Robertson DL, Morrison SG, et al: The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. J Virol 1996; 70: 7013-7029.
9. 9. Carr JK, Salminen MO, Koch C, et al.: Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand. J Virol 1996; 70: 5935-5943.
10. 10. Carr J, Foley B, Leitner T, Korber B, and McCutchan F: Reference sequences representing the principal genetic diversity of HIV -1 in the pandemic. In: Human Retroviruses and AIDS. Los Alamos National Laboratory, Los Alamos, New Mexico, 1998.
11. 11. Descamps D, Collin G, Loussert-Ajaka I, Saragosti S, Simon F, and Brun-Vézinet F: HIV-1 group O sensitivity to antiretroviral drugs. AIDS 1995; 9: 977-978.
12. 12. Apetrei C, Descamps D, Collin G, et al.: Human immunodeficiency virus type 1 subtype F reverse transcriptase sequence and drug susceptibility. J Virol 1998; 72: 3534-3538.
13. 13. Descamps D, Apetrei C, Collin G, Damond F, Simon F, and Brun-Vé zinet F: Naturally occurring decreased susceptibility of HIV-1 subtype G to protease inhibitors. AIDS 1998; 12: 1109-1111.
14. 14. Loussert-Ajaka I, Ly TD, Chaix ML, et al.: HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients. Lancet 1994; 343: 1393-1394.
15. 15. Schable C, Zekeng L, Pau C, et al.: Sensitivity of United States HIV antibody tests for detection of HIV-1 group O infections. Lancet 1994; 344: 1333-1334.
16. 16. Apetrei C, Loussert-Ajaka I, Descamps D, et al.: Lack of screening test sensitivity during HIV-1 non-subtype B seroconversions. AIDS 1996; 10: F57-F60.
17. 17. Loussert-Ajaka I, Descamp D, Simon F, Brun-Vé zinet F, Ekwalanga M, and Saragosti S: Genetic diversity and HIV detection by polymerase chain reaction. Lancet 1995; 346: 912-913.
18. 18. Coste J, Montes B, Reynes J, et al.: Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma. J Med Virol 1996; 50: 293-302.
19. 19. Triques K, Coste J, Perret JL, et al.: Efficiency of four versions of the Amplicor HIV-1 monitor test to quantify HIV-1 from different subtypes: 3 versions (1.0, 1.0+, 1.5) with different gag primers and a prototype automated test of version 1.5. J Clin Microbiol 1999; 37: 110-116.
20. 20. Williams E, Mohamed I, Chokwern JO, et al.: HIV-1 and HIV-2 antibodies in Nigerian populations with high and low risk behaviour patterns. AIDS 1990; 4: 1041-1042.
21. 21. Harry TO, Ekkena O, Chikwem JO, et al.: Seroepidemiology of human immunodeficiency virus infection in Borno State of Nigeria by sentinel surveillance. J Acquir Immune Defic Syndr 1993; 6: 99-103.
22. 22. Abimiku AG, Zwandor A, Gomwalk N, et al.: HIV-1, not HIV-2 is prevalent in Nigeria: Need for consideration in vaccine plans. Vaccine Res 1994; 3: 101-103.
23. 23. Esu-Williams E, Mulanga-Kabeya C, Takena H, et al.: Seroprevalence of HIV-1, HIV-2 and HIV-1 group O in Nigeria: Evidence for a growing increase of HIV infection. J Acquir Immune Defic Syndr 1997; 16: 204-210.
24. 24. Dada AJ, Oyewole FR, Onofowokan R, et al.: Demographic characteristics of retroviral infections (HIV-1, HIV-2 and HTLV-I) among female professional sex workers in Lagos, Nigeria. J Acquir Immune Defic Syndr 1993; 6: 1358-1363.
25. 25. Olaleye OD, Bernstein L, Ekweozor CC, et al.: Prevalence of human immunodeficiency virus type 1 and 2 infections in Nigeria. J Infect Dis 1993; 163: 710-714.
26. 26. Carr JK, Salminen MO, Albert J, et al.: Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants. Virology 1998; 247: 22-31.
27. 27. Gao F, Robertson DL, Carruthers CD, et al.: A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1. J Virol 1998; 72: 5680-5698.
28. 28. McCutchan FE, Carr JK, Bajani M, et al.: Subtype G and multiple forms of A/G intersubtype recombinant human immunodeficiency virus type 1 in Nigeria. Virology 1999; 254: 226-234.
29. 29. Mulanga-Kabeya C, Williams EE, Eni E, et al.: Evidence for HIV-1 group O infection in Nigeria. Lancet 1995; 346: 308.
30. 30. Delwart EL, Shpaer EG, Louwagie J, et al.: Genetic relationships determined by a DNA heteroduplex mobility assay: Analysis of HIV-1 env genes. Science 1993; 262: 1257-1261.
31. 31. Sanders-Buell E, Salminen MO, and McCutchan FE: Sequencing primers for HIV-1. In: Human Retroviruses and AIDS, part III. Los Alamos National Laboratory, Los Alamos, New Mexico, 1995, pp. 15-21.
32. 32. Thompson JD, Higgins DG, and Gibson TJ: CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994; 22: 4673-4680.
33. 33. Kimura M: A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 1980; 16: 111-120.
34. 34. Bibollet-Ruche F, Peeters M, Mboup S, et al.: Molecular characterization of the envelope transmembrane glycoprotein of 13 new human immunodeficiency virus type 1 group O strains from 6 different African countries. AIDS Res Hum Retroviruses 1998; 14: 1281-1285.
35. 35. Fransen K, Zhong P, De Beenhouwer H, et al.: Design and evaluation of universal primers for polymerase chain reaction detection of HIV-1 infected primary lymphocytes. Mol Cell Probes 1994; 8: 317-322.
36. 36. Triques K, Bourgeois A, Saragosti S, et al.: High diversity of HIV-1 subtype F strains in Central Africa. Virology 1999; 259: 99-109.
37. 37. Triques K, Bourgeois A, Vidal N, et al.: Near-full length genome sequencing of divergent African HIV-1 subtype F viruses leads to the identification of a new HIV-1 subtype designated K. AIDS Res Hum Retroviruses 2000; 16: 139-151.
38. 38. Howard TM, Olaylele DO, and Rasheed S: Sequence analysis of the glycoprotein 120 coding region of a new HIV type 1 subtype A strain (HIV-1IbNg) from Nigeria. AIDS Res Hum Retroviruses 1994; 10: 1755-1757.
39. 39. Howard TM and Rasheed S: Genomic structure and nucleotide sequence analysis of a new HIV type 1 subtype A strain from Nigeria. AIDS Res Human Retroviruses 1996; 12: 1413-1425.
40. 40. Montavon C, Toure-Kane C, Liegeois F, et al.: The majority of env and gag subtype A HIV-1 viruses circulating in West and West Central Africa are recombinant AG-IBNG-like strains. J Acquir Immune Defic Syndr 2000; accepted for publication.
41. 41. Nkengasong JN, Janssens W, Heyndrickx L, et al.: Genotypic subtypes of HIV-1 in Cameroon. AIDS 1994; 8: 1405-1412.
42. 42. Takehisa J, Zekeng L, Ido E, et al.: Various types of HIV mixed infections in Cameroon. Virology 1998; 245: 1-10.
43. 43. Brodine SK, Mascola JR, and Weiss PJ: Detection of diverse HIV-1 genetic subtypes in the USA. Lancet 1995; 346: 1198-1199.
44. 44. Heyndrickx L, Janssens W, Coppens S, et al.: HIV type 1 C2V3 env diversity among Belgian individuals. AIDS Res Hum Retroviruses 1998; 14: 1291-1296.
45. 45. Lasky M, Perret JL, Peeters M, et al.: Presence of multiple non-B subtypes and divergent subtype B strains of HIV-1 in individuals infected after overseas deployment. AIDS 1997; 11: 43-51.
46. 46. Peeters M, Liegeois F, Torimiro N, et al.: Characterization of a highly replicative intergroup M/O recombinant HIV-1 virus isolated from a Cameroonian patient. J Virol 1999; 73: 7368-7375.